SEC Form 4 · accession 0001480097-15-000002
AOXING PHARMACEUTICAL COMPANY, INC. · AXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilfred Chow
Officer — Chief Financial Officer
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 2:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | A | 812,500 | $0.32 | A | 1,112,500 | D |
Table II — derivative securities
No Table II lines on this filing.